Group One Trading »

Revance Therapeutics shares owned by Group One Trading

Quarter-by-quarter ownership of Revance Therapeutics shares owned by Group One Trading from 13F filings

Historical chart of Group One Trading investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Group One Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $287k 58k 4.92
2023-09-30 $3.8M 334k 11.47
2023-06-30 $7.3M 287k 25.31
2023-03-31 $7.9M 247k 32.21
2022-12-31 $3.4M 185k 18.46
2022-09-30 $2.5M 92k 27.00
2022-06-30 $1.6M 116k 13.82
2022-03-31 $277k 14k 19.51
2021-09-30 $11k 400 27.50
2021-06-30 $12k 400 30.00
2021-03-31 $98k 3.5k 28.00
2020-06-30 $176k 7.2k 24.44
2020-03-31 $110k 7.4k 14.86
2018-09-30 $22k 900 24.44
2018-06-30 $30k 1.1k 27.27
2018-03-31 $6.0k 200 30.00
2017-12-31 $626k 18k 35.77
2016-09-30 $8.0k 500 16.00
2016-06-30 $30k 2.2k 13.64
2016-03-31 $108k 6.2k 17.42
2015-12-31 $184k 5.4k 34.07
2015-03-31 $4.0k 200 20.00
2014-12-31 $46k 2.7k 17.04

Top funds holding Revance Therapeutics